MENLO PARK, Calif. — Gamma Biosciences, a global life sciences company formed by KKR to serve the advanced therapy market with best-in-class bioprocessing solutions, today announced that Kieran P. Murphy will join its Board of Directors as Executive Chairman. With a long track record of building leading businesses in biopharma and life sciences, Mr. Murphy […]
Financing demonstrates the value of Laminar Wash technology in accelerating and standardizing therapeutic research and development WOBURN, Mass. — Curiox Biosystems, Inc., the global leader in biological sample preparation automation, announced today the completion of a $15 million (17.1 billion won) Series C financing round. Luha Private Equity led the deal, joined by other existing investors KB Investment Co., […]
San Diego, Calif. – Arima Genomics, Inc., the leader in 3D genomics, today announced the close of its $7 million Series B Preferred Stock financing round. New investors Genetron Health (NASDAQ: GTH), Tech Coast Angels, Ladder Ventures, and Hiaqua Investments were joined by existing investors Agilent Technologies (NYSE: A), Co-win Ventures, Vectr Ventures and Berkeley […]
RNA is increasingly the focus of medicine, new therapeutics, and vaccines Eclipsebio leads the field of RNA genomics with a suite of data-driven technologies revealing RNA structure, modifications, interactions, and translation Eclipsebio plans to leverage this capital raise to accelerate the development of pipeline technologies and products SAN DIEGO — Eclipse Bioinnovations, Inc. (Eclipsebio), the leading […]
LEIDEN – BIOKÉ announced it has signed a distribution agreement with Applied Cells Inc to distribute the MARS® technology in the Netherlands, Belgium, and Luxembourg (Benelux), effective immediately. Applied Cells is a leading provider of cell preparation and isolation solutions for tumor biology, cell therapy, and genomics research. Their proprietary innovative MARS platform, short-named after […]
NEW YORK — Opentrons Robotics today announced the largest expansion of its automation portfolio to date, launching four new OT-2 workstation products supporting popular applications, including NGS, PCR and protein purification. These launches build on the success of the OT-2 COVID-19 workstations, which have been used by hundreds of labs around the world to rapidly […]
London, UK – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces that Nick McCooke, widely recognised leader in the next generation sequencing (NGS) field, has been appointed as Strategic Advisor. Nick was the founding CEO of pioneering NGS company Solexa, which he took from spin-out to its NASDAQ listing in 2005. Solexa was […]
The bioautomation company emerges from stealth mode with investment led by Maverick Ventures and John Stuepelnagel (co-founder of Illumina) CAMBRIDGE, MA – Volta Labs, a bioautomation company developing solutions to streamline the upstream workflows in genomic sequencing, today announced it raised $20 million in a Series A funding round. The round was led by Maverick […]
Cologne BioEcho Life Sciences GmbH, an innovative manufacturer of nucleic acid purification solutions for molecular diagnostics and life sciences research, today announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors. Ampersand’s investment will be used to support the company’s worldwide […]
sparQ RNA-Seq HMR Kit generates high-quality Illumina® NGS sequencer-ready libraries from intact or degraded samples in a single day BEVERLY, Mass. – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced the commercial availability of the sparQ RNA-Seq HMR Kit, an […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
